Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

146 ta ish

Ish: <scp>IL</scp> ‐6/ <scp>IL</scp> ‐ <scp>6R</scp> ‐Mediated Mechanisms in Lung Cancer: From Pathogenesis to Potential Therapeutic Targets

  1. Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs

    Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13

    Maqola202512 iqtibos
    ABI

  2. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer

    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6

    Sharh maqola20218 iqtibos
    ABI

  3. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Maqola20216 iqtibos
    ABI

  4. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

    Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7

    Sharh maqola20196 iqtibos
    ABI

  5. EP4 receptor as a novel promising therapeutic target in colon cancer

    Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5

    Sharh maqola20206 iqtibos
    ABI

  6. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

    Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11

    Maqola20246 iqtibos
    ABI

  7. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    MaqolaOchiq kirish20235 iqtibos
    ABI

  8. NF-κB, inflammation, immunity and cancer: coming of age

    Koji Taniguchi, Michael Karin

    Sharh maqola20185 iqtibos
    ABI

  9. The molecular biology and therapeutic potential of Nrf2 in leukemia

    Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6

    Sharh maqola20225 iqtibos
    ABI

  10. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

    Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

    Maqola20254 iqtibos
    ABI

  11. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression

    Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani +12

    Maqola20204 iqtibos
    ABI

  12. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

    Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

    Sharh maqola20224 iqtibos
    ABI

  13. Cancer Progress and Priorities: Lung Cancer

    Matthew B. Schabath, Michele L. Coté

    Sharh maqola20193 iqtibos
    ABI

  14. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses

    Sara Adibfar, Ali Masjedi, Atefeh Nazer +9

    Maqola20223 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa3 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI